tradingkey.logo
tradingkey.logo
Pesquisar

AVITA Medical Inc

RCEL
Adicionar à lista de desejos
5.060USD
+0.390+8.35%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
155.73MValor de mercado
PerdaP/L TTM

Mais detalhes de AVITA Medical Inc Empresa

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

Informações de AVITA Medical Inc

Código da empresaRCEL
Nome da EmpresaAVITA Medical Inc
Data de listagemMar 18, 2012
CEOVance (Cary G)
Número de funcionários260
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 18
Endereço28159 Avenue Stanford
CidadeVALENCIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91355
Telefone16613679170
Sitehttps://www.avitamedical.com/
Código da empresaRCEL
Data de listagemMar 18, 2012
CEOVance (Cary G)

Executivos da empresa AVITA Medical Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de AVITA Medical Inc?

Os cinco principais acionistas de AVITA Medical Inc são: Prof. Suzanne Crowe

Quantas instituições possuem ações da AVITA Medical Inc (RCEL)?

Em 2026Q1, 209 instituições possuíam ações da AVITA Medical Inc, com valor de mercado aproximado de 6.52M, representando 21.20% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1392153.00.